Journal article
Activation of Murine Immune Cells upon Co-culture with Plasma-treated B16F10 Melanoma Cells
Applied sciences, v 9(4), p660
15 Feb 2019
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Recent advances in melanoma therapy increased median survival in patients. However, death rates are still high, motivating the need of novel avenues in melanoma treatment. Cold physical plasma expels a cocktail of reactive species that have been suggested for cancer treatment. High species concentrations can be used to exploit apoptotic redox signaling pathways in tumor cells. Moreover, an immune-stimulatory role of plasma treatment, as well as plasma-killed tumor cells, was recently proposed, but studies using primary immune cells are scarce. To this end, we investigated the role of plasma-treated murine B16F10 melanoma cells in modulating murine immune cells' activation and marker profile. Melanoma cells exposed to plasma showed reduced metabolic and migratory activity, and an increased release of danger signals (ATP, CXCL1). This led to an altered cytokine profile with interleukin-1 (IL-1) and CCL4 being significantly increased in plasma-treated mono- and co-cultures with immune cells. In T cells, plasma-treated melanoma cells induced extracellular signal-regulated Kinase (ERK) phosphorylation and increased CD28 expression, suggesting their activation. In monocytes, CD115 expression was elevated as a marker for activation. In summary, here we provide proof of concept that plasma-killed tumor cells are recognized immunologically, and that plasma exerts stimulating effects on immune cells alone.
Metrics
Details
- Title
- Activation of Murine Immune Cells upon Co-culture with Plasma-treated B16F10 Melanoma Cells
- Creators
- Katrin Roedder - Leibniz Institute for Plasma Science and TechnologyJuliane Moritz - Leibniz Institute for Plasma Science and TechnologyVandana Miller - Drexel UniversityKlaus-Dieter Weltmann - Leibniz Institute for Plasma Science and TechnologyHans-Robert Metelmann - College Station Medical CenterRajesh Gandhirajan - Leibniz Institute for Plasma Science and TechnologySander Bekeschus - Leibniz Institute for Plasma Science and Technology
- Publication Details
- Applied sciences, v 9(4), p660
- Publisher
- Mdpi
- Number of pages
- 17
- Grant note
- 03Z22DN11 / German Federal Ministry of Education and Research (BMBF); Federal Ministry of Education & Research (BMBF)
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Microbiology and Immunology; Microbiology Department Internal Research
- Web of Science ID
- WOS:000460696500046
- Scopus ID
- 2-s2.0-85061633457
- Other Identifier
- 991021463437104721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- International collaboration
- Web of Science research areas
- Chemistry, Multidisciplinary
- Engineering, Multidisciplinary
- Materials Science, Multidisciplinary
- Physics, Applied